Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04765709Phase 2Terminated
Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC
Non-small Cell Lung Cancer Stage III
PrincipalinvestigatorStart date: 2021-09-24

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fondazione IRCCS ISTITUTO NAZIONALE TUMORI

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Carri Glide-Hurst, PhD, DABR, FAAPM

University of Wisconsin, Madison

Moderately Similar
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Esra Gümüştepe, M.D

Ankara University

Moderately Similar
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Michael Farris, MD

Wake Forest University Health Sciences

Moderately Similar
5 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Changli Wang

Tianjin Medical University Cancer Institute and Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Michael Farris, MD

Wake Forest Baptist Comprehensive Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Alexander Chi, MD

Capital Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Kathleen Castro, R.N.

National Cancer Institute (NCI)

Moderately Similar
3 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Sung Yong Lee, MD, PhD

Korea University Guro Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Thomas Dilling, MD

Moffitt Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III
Similarity Score30%

Charles Simone, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
4 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer Stage III

Worked with same sponsors:

AstraZeneca
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04765709Phase 2PrincipalInvestigator

Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC

Non-small Cell Lung Cancer Stage III
Terminated

All 1 trials loaded